1. Home
  2. Live Updates
  3. Lioma

Live Breaking News & Updates on Lioma

Stay informed with the latest breaking news from Lioma on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Lioma and stay connected to the pulse of your community

About Brain Tumor

Brain tumors are the abnormal growth of brain cells that may be benign or metastatic. Brain tumors account for about 2.4% of all the tumor diagnosesandare most challenging due to their critically delicate location.

Hippel-lindau , Li-fraumeni , General-info , Resonance-imaging , Brain-tumor , Lial-cells , Erve-cells , Hemical-reactions , Ereditary-disorders , Enign-tumor , Alignant-tumor

Study unmasks secrets of glioma's invasive margins

High-grade gliomas are cancerous tumors that spread quickly in the brain or spinal cord.

Arizona , United-states , Nhan-tran , Department-of-cancer-biology-at-mayo-clinic , Nature-communications , Mayo-clinic , Cancer-biology , Cell , Lioma , Iopsy , Rain , Rain-tumor

Non-destructive cancer grade probing system evaluates malignancy grade of model glioma cells

A water-soluble, luminescent europium complex enables evaluation of malignancy grade in model glioma tumor cells.

Japan , Shinya-tanaka , Yasuchika-hasegawa , Hokkaido-university , Institute-for-chemical-reaction-design , Professor-yasuchika-hasegawa , Professor-shinya-tanaka , Chemical-reaction-design , Cancer , Umor , Rain , Rain-tumor

Collaborative effort to develop AI-powered tools for glioma detection

Each year, about 22,000 individuals in the EU are diagnosed with a glioma, a malignant type of brain tumor. Median survival time after diagnosis can be as short as 15 months.

Stockholm , Sweden , Switzerland , Netherlands , Beatrice-melin , University-hospital-region , University-hospital , Brain , Rain-tumor , Lioma , Ospital , Alignant

Researchers introduce CRISPR-mediated genome and cancer shredding as a conceptual paradigm to treat recurrent gliomas

Researchers demonstrated clustered regularly interspersed short palindromic repeats (CRISPR)-mediated elimination of glioblastoma (GBM) cells.

Cell-reports , Cherry-tagged-cas , Cancer , Rispr , Enome , Liomas , As9 , Ell , Ell-death , Ell-line , Hemotherapy

New CRISPR approach shows promise for treating glioblastoma

The gene-editing technology CRISPR shows early promise as a therapeutic strategy for the aggressive and difficult-to-treat brain cancer known as primary glioblastoma, according to findings of a new study from Gladstone Institutes.

United-kingdom , Christof-fellmann , Jennifer-doudna , Doudna-gladstone , Alexendar-perez , Mitchel-berger , Brain-tumor-center , Cell-reports , Gladstone-senior-investigator-jennifer-doudna , I-li-tan , Brain , Rain-cancer

Peptide vaccine targets H3K27M mutation in midline gliomas, shows promise in early trials

Tumor vaccines can help the body fight cancer. These vaccines alert the patient's immune system to proteins that are carrying cancer-typical alterations.

Munich , Bayern , Germany , Berlin , Bonn , Nordrhein-westfalen , Heidelberg , Baden-wüberg , Mannheim , German , Katharina-sahm , Michael-platten

Implanted Microdevices Revolutionize Brain Cancer Treatment

Resembling a grain of rice, this innovative device conducts multiple experiments at once to assess the effects of new treatments on challenging brain cancers.

Pierpaolo-peruzzi , Department-of-neurosurgery-at-brigham , Mass-general-brigham , Science-translational , Brain-cancer , Rain-tumor , Lioma ,

New device can help test treatments in patients with gliomas

The shape and size of a grain of rice, the new device can conduct dozens of experiments at once to study the effects of new treatments on some of the hardest-to-treat brain cancers.

Oliver-jonas , Pierpaolo-peruzzi , Megan-craig , Department-of-neurosurgery-at-brigham , Mass-general-brigham , Science-translational , Brain , Ancer , Linical-trial , Rugs , Lioma , Liomas

New drug candidate nearly doubles survival for patients with aggressive childhood brain tumors

For the first time, researchers have found a potential drug candidate that improved outcomes for patients with a type of childhood brain tumor for which there are no effective treatments.

Michigan , United-states , Chad , American , Carl-koschmann , Megan-craig , Sriram-venneti , Chad-carr-pediatric-brain-tumor-center , University-of-michigan-health-rogel-cancer-center , Um-chad-carr-pediatric-brain-tumor-center , American-association-for-cancer-research , Michigan-health-rogel-cancer-center